Paula Amato

Paula Amato is a reproductive endocrinologist and infertility specialist with expertise in embryo research, genetic analysis, and transgender healthcare. She is certified by the Royal College of Physicians and Surgeons of Canada (1994) and the American Board of Obstetrics and Gynecology (1998), and holds memberships in the American Congress of Obstetricians and Gynecologists.

• MD, University of Toronto (1989)
• Residency in Obstetrics and Gynecology, University of Toronto (1994)
• Fellowship in Reproductive Endocrinology and Infertility, University of California-San Diego (1997)

Her research focuses on reproductive disparities, genetic mutations in oocytes, ethical implications of embryo research, and the intersection of reproductive medicine with environmental factors (e.g., wildfire-related impacts on fertility). She has contributed to advancements in mitochondrial DNA transfer and somatic cell reprogramming. Her publications highlight collaborations across disciplines, including bioethics, genetics, and clinical obstetrics.

Recent publications include studies on LGBTQ+ reproductive outcomes, genetic parenthood preferences in transgender patients, and technical innovations in embryo viability assessments. She has also collaborated on high-impact debates about CRISPR-Cas9 applications in human embryos.

• American Congress of Obstetricians and Gynecologists